Watch this Reel on FacebookBangalore, June 25, 2024 – Apollo Cancer Centres (ACC), in association with Accuracy, a global provider of radiation therapy devices, today announced the launch of India Sub-Continent’s first robotic and stereotactic therapy education centre, Robotic & Stereotactic Radiosurgery program. This initiative will be established at ACC in Chennai and Bangalore, and will provide advanced radiosurgery educational training to radiation oncologists, physicists, radiation therapists, and technologists from India and across the India Sub-continent.The program includes comprehensive discussions, demonstrations, and hands-on training focusing on robotic and stereotactic radiosurgery. This initiative marks a significant milestone in India’s medical education landscape, making world-class training available locally.Participants will engage in in-depth discussions, and demonstrations ensuring a robust and practical learning experience.Mr Dinesh Madhavan, President Group Oncology, and International, Apollo Hospital Enterprises Ltd, said, “In the field of cancer care ground-breaking technologies pave the way for highly personalized and effective treatment. The inception of the Robotic Stereotactic Radiotherapy Program by Apollo Cancer Centres and Accuray will advance training facilities for the ASEAN region. It will help equip oncologists, physicists, and therapists with the critical knowledge and skills needed to leverage the latest in CyberKnife technology. ”Dr Sridhar PS, Lead- Cyberknife – Robotic Radiosurgery, said, “The launch of the training program at Apollo Cancer Centre is an exceptional opportunity to enhance skills and knowledge in Robotic & Stereotactic Radiotherapy . Since pioneering the Cyberknife Robotic Radio Surgery System in India and a rich experience of over 5000 patients, we will now share the valuable knowledge in the training program. It will enable oncologists in the development of Cancer care through Cyberknife training.”Dr Manish Mattoo, CEO, Karnataka and Central Region, said, “Introducing this state-of-the-art Robotic Stereotactic Radiotherapy Program aligns perfectly with our mission to provide top-class cancer care. The CyberKnife training will enhance the capabilities of oncologists and medical staff, allowing them to offer the latest in cancer treatment technologies right here in India Sub- Continent.”Ms Suzanne Winter, President & CEO, Accuracy, said, “Accuracy celebrates the expansion of the CyberKnife® S7™ System to Apollo centers in Chennai and Bangalore, showcasing our enduring collaboration with Apollo Hospitals to enhance cancer care in India. With its unparalleled precision, the CyberKnife S7 System redefines treatment standards, empowering clinicians to optimize outcomes. Additionally, it enables the delivery of high doses of radiation, typically in 1 to 5 sessions for fast and effective treatments, marking a significant advancement in cancer therapy.”The CyberKnife System is a non-invasive, robotic radiation therapy device designed to treat tumors with high precision and minimal damage to surrounding healthy tissue. It uses advanced imaging and computerized robotics to deliver highly focused beams of radiation, allowing for the treatment of complex and hard-to-reach tumors.With an aim to provide a world-class comprehensive ‘Educational Center’, the Academia will benefit aspiring CyberKnife clinicians of India and the Subcontinent.By bringing such a high-caliber educational initiative to India, Apollo Cancer Centres continues to lead the way in medical innovation, dedicated to enhancing the skills of healthcare professionals and ultimately, improving patient outcomes across the country.

Apollo Hospitals and The Live Love Laugh Foundation join hands to raise mental health awareness among doctors~ Programme will cover 1200 doctors across 64 locations in India ~Hyderabad, April 6th, 2017: Apollo Hospitals has partnered with The Live Love Laugh Foundation to raise awareness on Mental Health via the foundation’s “Together Against Depression” programme designed for doctors. This was announced by Dr K Hari Prasad, President – Hospital Division, Apollo Hospitals; Dr Shyam Bhat, Trustee – The Live Love Laugh Foundation and Dr J Srikanth, Sr. Consultant – Internal Medicine, Apollo Hospitals; at a press conference on Thursday, on the eve of World Health Day – April 7th, 2017, with this year’s theme being ‘Depression.’Through the conduct of this sensitization programme, Apollo Hospitals’ 7000-strong clinician workforce will lead the way to help break down the stigma surrounding mental health and depression, with the aim of ultimately encouraging people going through tough times to seek help.Spread across geographies with 60+ hospitals, clinics and pharmacies the Apollo Hospitals group has been a pioneer in taking up issues of health and wellness. In line with the vision of the founding Chairman, the partnership The Live Love Laugh Foundation will aim to conduct 24 sessions over the coming months covering ~ 1200 doctors.A not-for-profit organization with a focus on mental health awareness, The Live Love Laugh Foundation, led by its founder Ms. Deepika Padukone, has already conducted the programme for ~ 2,000 other doctors around the country over the last 12 months. With Apollo, the scale of the programme will be expanded further.This programme for doctors on mental health is in line with the MCI’s (Medical Council of India) new guidelines that state that 10% of all medical education programmes in India should focus on mental health.Depression affects people of all ages, from all walks of life, in all countries. It causes mental anguish and impacts on people’s ability to carry out even the simplest everyday tasks, with sometimes devastating consequences for relationships with family and friends and the ability to earn a living.At worst, depression can lead to suicide, now the second leading cause of death among 15-29-year-olds.Yet, depression can be prevented and treated. A better understanding of what depression is,and how it can be prevented and treated, will help reduce the stigma associated with the condition, and lead to more people seeking help.“The theme for this years’ World Health Day is Depression, and it is Apollo’s endeavor to be a pioneer in the health and wellness space. The collaborative program with The Live Love Laugh Foundation is aimed to raise awareness about mental health issues and ensure that Doctors, the first line of defense, are prepared. Many individuals go through stress and anxiety related to work and personal life, a doctor is well equipped to direct the patient towards the required help. Any chronic condition may heighten the risk of a patient developing symptoms of anxiety, stress and depression. A doctor is a trusted health partner and will be able to channel the patient towards help,” according to Dr. K Hari Prasad, President, Apollo Hospitals.“Medical practitioners can be the core of the fight against depression as they are often the primary touch point for those affected. The importance of talking about depression as a vital component of recovery and can be initiated by them. Doctors can play a vital role to reduce the stigma surrounding mental illness, including depression, which remains a barrier to people seeking help throughout the world. ‘Together Against Depression’ will equip doctors with the right skills and resources to be key influencers in the fight against depression,” said Dr. Shyam Bhat, Trustee – The Live Love Laugh Foundation.The programme which will rolled across the locations of Apollo Hospitals around the country, will coverage a range of topics related to depression and its incidence, screening and treatment. The program participants will also receive material such as videos, articles, quizzes and handouts for easy reference.About Apollo HospitalsIt was in 1983, that Dr. Prathap Reddy made a pioneering endeavor by launching India’s first corporate hospital – Apollo Hospital in Chennai. Now, as Asia largest and most trusted healthcare group, its presence includes more than 10000 beds across 65 Hospitals, 2000 Pharmacies, 92 Primary Care and Diagnostic Clinics, 100 Telemedicine units across 10 countries. Health Insurance services, Global Projects Consultancy, 15 colleges of Nursing and Hospital Management and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research and the first Proton Therapy Center across Asia, Africa and Australia.In a rare honor, the Government of India issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 30 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.About The Live Love Laugh FoundationThe Live Love Laugh Foundation was set up in 2015 as a Charitable Trust to champion the cause of mental health in India and focus on depression in particular. The main aim of TLLLF is to reduce social stigma and create awareness around mental health. TLLLF has spread awareness on mental health via the foundation’s English / Hindi website (www.thelivelovelaughfoundation.org / www.thelivelovelaughfoundation.org/hi), extensive engagement via the foundation’s social media channels, outreach to various print, TV, radio and digital media outlets, and by undertaking several on-ground activities such as a mental health awareness program (“You Are Not Alone”) for school students and teachers which has been already conducted more than 230+ schools, reaching more than 32,000 students and 6,700 teachers around the country. The foundation’s sensitization program on mental health for doctors (“Together Against Depression”) has so far covered more than 2,000 doctors. The Live Love Laugh Foundation launched the country’s first nationwide public awareness campaign on mental health, the widely acclaimed Doobara Poocho, on October 10th 2016, World Mental Health Day.   

In a powerful display of solidarity and support, Apollo Proton Cancer Centre (APCC), Apollo Cancer Centres (ACC) and Apollo Shine hosted the third edition of the ‘Winners on Wheels’ Cyclathon. The event was aimed at raising awareness about sarcoma and inspire hope for improved quality of life after treatment. Sarcoma, a rare and often misunderstood cancer, predominantly affects children. By bringing cancer survivors, healthcare professionals and cycling enthusiasts together, the Cyclathon celebrated the indomitable human spirit and highlighted the importance of awareness and support for sarcoma.The event flagged-off by the Hon’ble Thiru Anbil Mahesh Poyyamozhi, Minister for School Education, Government of Tamil Nadu and Mr. Harshad Reddy, Director of Group Oncology & International at Apollo Hospitals Enterprises Limited (AHEL), attracted an enthusiastic crowd of over 200 participants. Among them were sarcoma survivors, school students, doctors and medical staff, all united in their endeavor to dispel cancer myths and honour the unbreakable human spirit.The Hon’ble Thiru Anbil Mahesh Poyyamozhi, Minister for School Education, Government of Tamil Nadu, while expressing his admiration for this social cause initiative, commented “I applaud Apollo team for their tireless efforts in raising awareness about Sarcoma through the ‘Winners on Wheels’ Cyclathon. This event embodies the spirit of tenacity and hope that personifies our State. By supporting cancer winners and their families, we can create a ripple effect of positivity and empowerment. I pledge my support to this noble cause and encourage everyone to join hands in the fight against cancer.”The 3rd edition, which comprised a 5-km Cyclathon, was flagged-off at APCC to spread the powerful message that “There is Life Beyond Cancer” and there is no challenge that can deter cancer warriors from achieving their goals. The inspiring event showcased sarcoma survivors leading the charge, symbolizing the unwavering strength and determination of those battling cancer.Dr Vishnu Ramanujan, Consultant- Orthopaedic Oncology, Apollo Proton Cancer Centres, said, “Sarcoma is a complex and formidable cancer, and it requires a multi-disciplinary approach to tackle its unique challenges. Having witnessed the impact it has on patients and their families, I believe, it demands personalized care, multi-modal treatment approach, counselling and unwavering support. The first step boils down to raising awareness and breaking the myths surrounding this cancer. Through the Winners on Wheels Cyclathon, we aim to break the silence surrounding sarcoma and provide a platform for survivors to share their inspiring stories of courage.”Speaking at the event, Mr. Harshad Reddy, Director Group Oncology & International, AHEL, emphasized, “Winners on Wheels is more than just a cyclathon – it’s a symbol of hope and triumph over cancer. Witnessing the determination and resilience of the cancer survivors and the enthusiasm of the young participants was truly inspiring. We are on wheels busting myths and showcasing that life beyond cancer is possible. We are not just raising awareness, but also nurturing a sense of togetherness and empowerment.”The Cyclathon commenced early in the morning with participants embarking on a scenic route that symbolized their journey of overcoming cancer. The event was filled with energy and a sense of community, underscoring the message that together we can conquer cancer.The ‘Winners on Wheels’ Cyclathon concluded with a ceremony honouring the sarcoma winners, who were celebrated not just for their participation but also for their relentless fight against cancer.

May 08, 2024: Cancer remains the illness most feared across the globe. But to combat these ongoing challenges, cancer diagnostics techniques and technology advancements are helping early detection rates, improving life expectancy, and bringing us closer to cancer care.In this ongoing fight against cancer, treatments are being revamped by adopting modern technologies that have moved cancer care forward by leaps and bounds. To win over cancer, Apollo Cancer Centre (ACC), Bengaluru, successfully conducted Karnataka’s first Robotic Nipple Sparing Mastectomy (RNSM)–a cutting-edge surgical technique—to treat breast cancer. In India, breast cancer rates are notably high, especially among young women, constituting 48% of cases.Led by Dr Jayanti Thumsi, Lead Consultant -Breast Oncology at ACC, Bengaluru— the country’s first lady surgeon trained in Robotic Breast Surgery—the RNSM procedure was conducted on 28-year-old Bangalore-based Ms Lalitha Sridhar (name changed on request) and 52-year-old Aarthi Sekhara (name changed on request).The technique combines robotic technology with advanced breast cancer treatment. Through a small almost invisible incision, robotic surgery enables precise mastectomy while sparing and safeguarding nipple and surrounding skin.Additionally, it facilitates breast reconstruction during the same procedure, offering patients several advantages. These benefits include reduced scarring, quicker recovery times, and improved cosmetic outcomes thus providing better patient satisfaction compared to the traditional mastectomy techniques.Ms Sridhar’s, reports suggested multi-centric disease and DCIS (Ductal Carcinoma in situ) which if untreated had a high chance of becoming malignant. A mastectomy was the only option and she was not ready to lose her breast. The doctors performed RNSM with implant reconstruction through a small incision where a 4 cm lateral cut was made under her arm, the muscle was dissected, and the cancerous breast was removed post which, the implant and reconstruction surgery was conducted.Before visiting ACC, many doctors brushed aside stating it’s “normal”.Meanwhile, Ms Sekhara was diagnosed with breast cancer a year ago and had multiple cancerous lumps in all the quadrants of her right breast. She was diagnosed with aggressive type of breast cancer called the Triple Negative Breast Cancer. She underwent immunotherapy and eight cycles of neoadjuvant chemotherapy, after which, the entire lump and axilliary nodes were removed. An RNSM with implant reconstruction was conducted and today, she is recovering, pain-free, and is healthier than she was six months ago.Dr. Jayanti Thumsi, Lead Surgeon–Breast Oncology at ACC, Bengaluru, said “Despite the high prevalence, breast cancer survival rates have significantly improved due to early detection and advanced therapies. With this innovation, our focus is not just on clearing cancer but ensuring a good quality of life for the patients. Unlike the traditional mastectomy that leads to compromising the aesthetics of femininity, the innovative surgery such as RNSM provides a significant impact on the physical and emotional aspects of the patient.”Dr. Vishwanath S, Senior Consultant, Medical Oncology, ACC, Bengaluru, said, “Robotic nipple sparing mastectomy is one of the novel and promising surgical techniques which is considered to be safe, reducing the chances of skin and nipple complications (necrosis) with early wound healing facilitating early delivery of chemotherapy, with better post-surgical quality of life and physical /sexual well being.”year-old Ms Lalitha Sridhar (name changed on request) said, “I am happy to have made the right decision and opted for RNSM. This technique spared me from taking chemotherapy or radiation. If I had left it for a longer time then I would have had 88% chances of pre-cancerous breast lump to have turned into a full-fledged cancer.” Ms Sridhar was discharged on the third day post-surgery.Mr. Dinesh Madhavan, President- Group Oncology & International, Apollo Hospitals Enterprise Ltd, said, “Robotics has revolutionized cancer care, implementation of advanced materials and designs along with the integration of imaging and visualization technologies have enhanced surgical accuracy and faster recovery. The use of artificial intelligence and machine learning aids in surgical decision-making by improving the recognition of minute and complex anatomical structures. Advancements through Robotic procedures like Robotic Nipple Sparing Mastectomy (RNSM) have led to faster recovery and fewer complications in patients. The growth curve of robotic surgery points to innovation and the RNSM by Apollo stand as a testament to the persistent pursuit of progress in healthcare”Mr. Tapan Desai, Area Sales Director, Intuitive, said, “Intuitive is excited to celebrate yet another milestone with Apollo Hospitals as they complete a robotic mastectomy procedure. This accomplishment underscores our shared commitment to advancing surgical innovation and enhancing patient care. We commend the skilled surgical team at Apollo Hospitals for their dedication to leveraging cutting-edge technology for the benefit of their patients.”#WinningOverCancerAbout Apollo Cancer Centres – https://apollocancercentres.com/THE CANCER CARE LEGACY: BREATHING HOPE INTO LIVES FOR OVER 30 YEARSCancer care today means 360-degree comprehensive care, which requires commitment, expertise, and an indomitable spirit from cancer specialists.Apollo Cancer Centres has a network across India with over 325 oncologists to oversee the delivery of high-end precision Oncology Therapy. Our oncologists deliver world-class cancer care following an organ-based practice under competent Cancer Management Teams. This helps us in delivering exemplary treatment to the patient in an environment that has consistently delivered an international standard of clinical outcomes.Today, people from 147 countries come to India for cancer treatment at Apollo Cancer Centres. With the first and only Pencil Beam Proton Therapy Centre in South Asia & Middle East, Apollo Cancer Centres.

In a remarkable medical breakthrough, Apollo Hospital Chennai has successfully used Topical Oxygen Therapy (TOT) to prevent the amputation of a 58-year-old man’s foot, demonstrating a 90% success rate in treating diabetic foot ulcers. This treatment not only preserved his foot but also set a precedent for handling complex medical cases in the region.A resident of West Bengal, grappling with a severe and debilitating foot ulcer due to poor blood circulation, was on the brink of losing his foot. After consulting another multispecialty hospital in Chennai which advised amputation, he sought alternatives. This search led him to Apollo Hospital Chennai, where he met Dr. Sivakumar N, Senior Consultant, Podiatric Surgery.The patient was presented with a neuroischemic ulcer, a serious condition that typically necessitates drastic measures such as below-knee amputation due to the risk of severe infection and complications. However, Apollo Hospital’s team of specialist doctors and its state-of-the-art facilities offered an alternative approach.Dr. Sivakumar and his team employed a two-pronged treatment strategy: Surgical Debridement and Decompression, which involved meticulously removing dead tissue and relieving pressure around the wound to prepare the site for healing. Following this, for three weeks, the patient underwent TOT, a cutting-edge treatment that delivers concentrated oxygen directly to the wound. This significantly enhanced the healing process by increasing oxygen availability, reducing bacterial growth, and stimulating new blood vessel formation.Following the treatment, the wound’s condition improved enough to allow for a split-skin grafting procedure, ultimately achieving complete wound closure. This series of treatments not only saved the patient’s foot from amputation but also significantly improved his quality of life, allowing him to walk unaided. Dr. Sivakumar N, Senior Consultant – Podiatric Surgery, shared, “By integrating Topical Oxygen Therapy with conventional surgical interventions, we are not only treating the wound but actively restoring the patient’s quality of life. This case highlights our commitment to advancing medical technology and our dedication to patient-centered care.”Topical Oxygen Therapy (TOT) is an advanced wound healing technique that delivers concentrated oxygen directly to the wound site. This method enhances the healing process by promoting the growth of healing cells, reducing bacterial growth, and stimulating new blood vessel formation. TOT is particularly effective for wounds with compromised blood flow, such as diabetic foot ulcers and post-surgical infections, and is often used alongside standard wound care practices.TOT has a success rate of approximately 90%, with its effectiveness influenced by factors like wound type, severity, and underlying health conditions. Apollo Hospital Chennai has successfully treated 10 cases with this procedure, demonstrating its efficacy in improving patient outcomes. Patients with chronic wounds, especially diabetic foot ulcers (DFUs) and ischemic wounds that show minimal progress with standard care, are eligible for TOT. Patients with active infections in the wound area and those with uncontrolled underlying medical conditions that can impede healing are not suited to undergo this therapy. The clinician assesses the wound characteristics, medical history, and patient’s overall health to determine if TOT is appropriate.The recovery journey with TOT varies depending on the severity and type of wound, with an average recovery time of three weeks. There is gradual wound closure and improvement in the surrounding tissue over time. TOT is used alongside standard wound care practices like debridement and proper wound dressings, which continue as part of the patient’s healing journey. Initial increased discharge from the wound may occur due to TOT’s ability to stimulate wound healing. The clinician closely monitors the wound for signs of healing. Since this therapy is topical, it carries very low systemic risk. Oxygen can promote bacterial growth; hence, it is crucial to ensure the wound is free from infection before starting TOT. Regular monitoring by the clinician is essential. Relapse is a possibility with any wound healing therapy, including TOT. Factors such as uncontrolled diabetes, poor circulation, or not following prescribed wound care protocols can influence relapse. Apollo Hospital Chennai’s experience with TOT has been positive, with no reported relapses to date.This case elucidates Apollo Hospital Chennai’s dedication to medical innovation and exceptional patient care. It showcases our ability to transform treatment options for severe medical conditions, providing hope and improved outcomes for patients facing challenging health issues.

Apollo Hospital, Chennai proudly announces a landmark achievement in Cardiology with the successful completion of the first-ever TRIC valve implantation in India in a patient with 2 existing prosthetic valves. This groundbreaking procedure offers a lifesaving alternative for patients with severe tricuspid regurgitation who are at high risk for traditional surgery. With this procedure, the patient acquired 4 prosthetic valves in his cardio-vascular system which is the first time in India.The recipient, a 71-year-old male with a complex history of cardiovascular issues including diabetes, hypertension, and previous 2 heart valve replacements (one open surgical and one TAVI valve done by us few months ago), presented with symptoms that significantly reduced his quality of life. Traditional surgery posed too great a risk due to his frail condition and multiple comorbidities.Apollo’s Chennai team, led by Dr. Refai Showkathali, Senior Consultant, Interventional Cardiology, opted for the pinhole (minimally invasive) TRIC valve approach. This innovative technique involves placing bioprosthetic valves in the major veins leading to the heart via a small pinhole procedure in the groin, significantly reducing surgical risks and recovery time.Upon careful evaluation, the team successfully implanted the TRIC valve system, which immediately improved the patient’s cardiac function. The procedure is a new option for high-risk patients who cannot tolerate open heart surgery. It uses two collapsible valves inserted through catheters in the groin. One valve goes in the large vein above the heart (superior vena cava), the other in the large vein below (inferior vena cava), helping reduce the backward flow of blood and easing the strain on the heart.Dr. Refai Showkathali, Senior Consultant, Interventional Cardiology, Apollo Hospitals, Chennai said, “The successful implementation of the TRIC valve at Apollo marks a significant advancement in cardiac care, not just for our hospital but for India. We have observed a remarkable procedural success rate with no deaths or conversions to open-heart surgery within the first 30 days post-operation. Compared to traditional open-heart surgery, the TRIC valve procedure allows for quicker recovery times and less discomfort, enabling patients to return to their daily activities much faster. This innovative treatment has led to significant improvements in patients’ quality of life and functional capacity, marking a major step forward in treating high-risk cardiac patients more safely and effectively.”The specific benefits of using the TRIC valve include:Minimally invasive: Reduces the risk of infection, bleeding, and damage to surrounding tissues. No anaesthesia needed: done under local anaesthesia. Fewer complications: Lower risk of complications like pneumonia, blood clots, and breathing problems compared to open-heart surgery. Faster recovery: Patients typically experience quicker recovery times, meaning shorter hospital stays and a faster return to daily activities. Less pain and reduced risk of long-term complications: Due to pinhole access and faster healing, patients generally experience less pain and are less likely to develop long-term complications.Post-operative assessments showed substantial improvement in heart performance and a significant reduction in symptoms, paving the way for a quicker and less painful recovery.The success of this first TRIC valve procedure in India highlights Apollo Hospital’s leadership in adopting and mastering cutting-edge medical technologies. It not only offers new hope for patients with severe cardiac conditions but also sets a new standard in the treatment possibilities available in India.

Renowned for its commitment to excellence in healthcare, Apollo Cancer Centre, Chennai (ACC), has achieved a ground-breaking surgical milestone by successfully performing South Asia’s first-ever robotic nipple-sparing mastectomy with immediate reconstruction. The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions, enabling aesthetic outcomes for the patient.Performed by Apollo Cancer Centres’ esteemed team of robotic surgical oncologists, led by Dr. Venkat P and Dr. Priya Kapoor, this innovative procedure marks a significant advancement in the field of breast cancer surgery.The surgery was conducted on a 37-year-old woman from Assam who was diagnosed with early-stage breast cancer and a BRCA1 mutation. Given her condition, a bilateral mastectomy with removal of both her ovaries prophylactically was required.Considering her age and the importance of preserving the natural appearance of her breasts, the approach chosen was a nipple-sparing mastectomy. This technique aims to minimize the impact on the patient’s quality of life by preserving an essential body marker for women and ensuring a more positive post-treatment experience.The surgeons followed specific protocols to successfully execute this surgery. Following neoadjuvant chemotherapy, the patient opted for bilateral mastectomy and prophylactic oophorectomy. The innovative Robotic Nipple Sparing Mastectomy (NSM) with Risk-Reducing Oophorectomy was performed, utilizing tiny incisions and leveraging the advantages of robotic surgery.The patient said, “The clinicians at Apollo Cancer Centre facilitated a remarkably swift recovery, enabling me to resume my normal routine within a week after a life-altering procedure. Dr. Venkat and the team allowed me to reclaim my life with dignity, preserving my natural appearance while conquering cancer. Today, I emerge stronger and with renewed hope.”Dr. Venkat P, Senior Consultant – Surgical Oncology, ACC Chennai, expressed his optimism about the future of robotic breast surgery in India, stating, “In our commitment to preserving the patient’s natural breast contour, we embraced the revolutionary approach of robotic bilateral mastectomy with risk-reducing oophorectomy. This cutting-edge, robotic-assisted technique not only provided superior visualization but also minimized blood loss, improved ergonomics, and delivered outstanding cosmetic outcomes. The patient’s successful & faster recovery aided for a discharge within 24 hours’ post-procedure.”Dr. Priya Kapoor, Consultant – Surgical Oncology, ACC Chennai, said, “The procedure not only removes the entire breast through discreet incisions but also increases the likelihood of preserving sensation in breast skin and nipple. The innovation goes beyond, leaving the nipple, skin, and breast intact even after surgery, preserving the entire shape of the breast. By introducing this new technique, we aim to provide our patients with the best possible cosmetic outcomes and ensure a better quality of life post-surgery.”Dr. Preetha Reddy, the Executive Vice Chairperson of Apollo Hospitals Enterprise Limited, expressed immense pride in a ground breaking achievement, stating, “It is exhilarating to witness the extraordinary triumph of our robotic surgical team, under the leadership of Dr. Venkat and Dr. Priya, in achieving South Asia’s inaugural robotic bilateral nipple-sparing mastectomy, with the Da Vinci Xi. The exceptional results of this innovative surgery herald the inauguration of RoBreaS, India’s premier robotic breast surgery program. Moreover, setting a new standard in surgical excellence, this effort paves the way for a future where advanced technology and compassionate care converge, igniting new hope in cancer care. At large, it is a testament to our unwavering dedication to offering superior treatment options, and make advanced healthcare much more accessible to all.”Breast cancer stands as the most prevalent cancer in women globally, and it ranks as the second leading cause of cancer-related deaths. Recognizing the increasing incidence of breast cancer, particularly in younger women, Apollo Cancer Centre has been at the forefront of adopting cutting-edge technologies to improve patient outcomes.

KOLKATA, October 07, 2021: For the first time in Eastern India, doctors at Apollo Multispecialty Hospital gave a new lease of life to an unborn by interstitial laser therapy using Diode laser. In Interstitial Diode Laser Therapy a fine needle is inserted into the mother’s womb to release some laser beams into the sick twin which gets terminated in the process to save its healthier co-twin. The procedure is conducted with the continuous support of ultrasound.Due to more people opting to become parents at a later age and hence the increase of IVF there has been a significant increase of twin babies around the world. Currently, one in fifty pregnancies have twin babies and twin pregnancies are always high-risk pregnancies. Among all twin pregnancies, about 66% are dichorionic (babies form from 2 separate eggs and sperms and have separate compartments with separate blood flow inside the uterus) and 33% are monochorionic (babies form from 1 egg and 1 sperm and have a common compartment with single blood flow inside the uterus).In the case of monochorionic twin pregnancy, there is a high chance of cross (selective) intrauterine growth restriction called Twin-to-twin-transfusion syndrome (TTTS), which is the most important cause of prenatal death of twins. The syndrome typically occurs in the second trimester in about 10-15% of monochorionic twin pregnancies and one of the babies don’t grow as expected and compared to the other. This happens as sharing the same placenta causes blood flow imbalance amongst the twins, where one foetus becomes the so-called donor twin and the other the recipient.If untreated, perinatal mortality is unavoidable as one baby dies due to lack of nutrition and the other due to overnutrition. Secondly, if there is any clot or cardiac dysfunction in the weaker baby due to lack of nourishment, the clot or cardiac issue gets transferred to the healthy baby as well through the common placenta causing the death of the healthy baby within 72 hours of the weaker baby’s death inside the foetus. In this case, the mother was detected with the issue at 14 weeks of pregnancy, when saving both the babies by ensuring proper growth inside the womb was impossible.Interstitial Laser Therapy is the only procedure that can save at least one baby out of the two. In a single treatment procedure, with help of ultrasound in order to see the foetus and placenta, the technique separates the connection of the vessels between the two babies. As a result of this, the weaker donor baby stops receiving nutrition while the healthy baby keeps growing inside the foetus.Dr Jayanta Kr Gupta, Director & HOD Obstetrics & Gynaecology, Apollo Multispecialty Hospitals, Kolkata said, “It’s indeed a tough decision for parents to let go of one of the twins before birth, but this is the only way to save the other baby or else both the babies can’t live. We here at Apollo for the very first time in Eastern India did the procedure of Interstitial Laser Therapy so that we can at least save one of the twins. The treatment was applied in a case of Twin-to-twin-transfusion syndrome (TTTS), which is unique to identical twins, who by nature get nutrition supplied by a single placenta. And we hope to perform on more pregnant women with Twin-to-twin-transfusion syndrome so that they don’t lose their babies due to this condition of intrauterine growth restriction. For this, early detection through regular check-ups including USG is critical during pregnancy.”About Apollo Hospitals Enterprise Ltd. (AHEL)It was in 1983, that Dr. Prathap C. Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai.Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 71 Hospitals, 3,300 Pharmacies, over 90 Primary Care Clinics and 150 diagnostic centres, 110 plus Telemedicine Centres, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research, Apollo Hospitals has been at the forefront of new medical advancements with the most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C. Reddy, was conferred with the prestigious Padma Vibhushan in 2010.For 35 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.For more information:Amitava Chakraborty | amitava_c@apollohospitals.com | 9804000201Sumantika Choudhury | sumantika.choudhury@adfactorspr.com| 9830056185

Fatty liver disease is rapidly becoming a major health concern in India. Studies suggest fatty liver affects a significant portion of the Indian population, with estimates ranging from 10% to 30%. India’s growing rates of obesity, diabetes, and unhealthy lifestyles contribute heavily to fatty liver. Often symptomless in the early stages, NAFLD can progress to serious complications like liver cirrhosis and liver failure if left unaddressed. Promoting healthy lifestyles with proper diet and exercise to manage weight and improve overall health.Apollo Hospitals, has inaugurated its latest endeavour, the Apollo Fatty Liver Clinic at Liver Diseases and Transplantation Institute, Apollo Hospitals, Chennai. This cutting-edge facility introduces the game-changing diagnostic marvel, ‘FibroScan Expert 630,’ poised to revolutionize liver care and tackle Non-Alcoholic Fatty Liver Disease (NAFLD) head-on. The Fatty Liver Clinic was inaugurated by the esteemed actor, Mr Prasanth Thiagarajan, marking a significant stride in Apollo Hospitals’ unwavering commitment to pioneering medical care.Apollo Fatty Liver Clinic features world’s most advanced diagnostic tools and offers newer pharmacological treatments for management of fatty liver.The key highlight, FibroScan Expert 630, is a state-of-the-art diagnostic tool that goes beyond the ordinary. This advanced equipment, enables spleen stiffness measurement, an embedded ultrasound guidance system, and precise risk stratification for advanced chronic liver disease patients, and it is a beacon of hope for optimised patient care.Dr. N Murugan, Senior Consultant Hepatologist, Apollo Hospitals, Chennai, said, “Fatty liver disease is increasing in our country due to changing lifestyle, sedentary habits and increasing stress; approximately 35 to 40% of our adult population may have fatty liver. Around a quarter of these patients may go on to develop advanced liver disease. Technology like the Fibroscan 630 helps us to accurately assess early signs of liver damage non-invasively, and treatment can then be given to prevent progression of liver disease in these patients”Mr. Prashanth said, “I extend my heartfelt wishes to Apollo Hospitals on the inauguration of the Advanced Liver Disease and Transplantation Institute. Recognizing the growing prevalence of liver diseases among people today, initiatives like this aimed at early detection and immediate intervention are pivotal in mitigating the risk of these conditions escalating into serious illnesses. Apollo’s proactive focus on prevention by treating it in the early stage itself is truly commendable and reflects their dedication to addressing this pressing health concern.”To celebrate this monumental launch, Apollo Hospitals is extending a gesture of care to the community. The first 75 individuals will receive complimentary check-ups at the hospital, offering an exclusive opportunity to experience advanced liver health assessments and consultations with leading specialists.The Liver Disease and Transplantation Institute, specialising in the diagnosis and treatment of liver conditions, with a unique focus on advancing care for NAFLD patients, embodies Apollo Hospitals’ mission to provide comprehensive and specialised healthcare services. This initiative is not just about treating ailments; it’s about ushering in a new era of wellness and pushing the boundaries of healthcare excellence.

Hyderabad, October 2021: The Apollo Hospitals Group, Asia’s foremost integrated healthcare services provider, today announced the launch of Varian’s TrueBeam radiotherapy system with Velocity, an intelligent software solution for interventional oncology at Apollo Cancer Institute, Apollo Health City campus, Hyderabad. The versatile TrueBeam is capable of treating a wide range of cancers with high accuracy and precision allowing oncologists or cancer specialists to treat many types of complex cancer cases. Patients also benefit due to the comfort, accuracy, and speed permitted by the TrueBeam system. The addition of the specialized software, Velocity, organizes patient data and makes it available in one place to help clinicians make more informed treatment decisions. Chief Guest Dr. (Smt.) Tamilisai Soundararajan, Hon’ble Governor of Telangana and Hon’ble Lt. Governor of Puducherry; inaugurated, Telangana’s first and only Truebeam STx with velocity, offering precision radiation and better clinical outcomes; at Apollo Cancer Centre, Jubilee Hills; today. Speaking on the occasion, she said, Apollo is known for offering the best care available in the world. It’s a moment of pride for Apollo Health City to have this state of the art TrueBeam radiotherapy system with Velocity, it also a moment of pride for the entire state of Telangana to have the latest and the only TrueBeam radiotherapy. The evolution of radiation therapy has enabled to deliver differential dose within the target volume, ranging from zero to 100% dose. Innovation in imaging for patient on treatment couch has improved the accuracy of radiation delivery, which is called the image guided radiation therapy, where the target is visualized every day prior to treatment, enabling the highest possible comfort. Today with the latest TrueBeam machine we have the capacity to treat cancer with all the very best of technology put together in 6D robotic couch and CG Image guidance for best accuracy in treatment. It delivers highly precise intensity modulated radiotherapy in the shortest possible time where the patient gets to go to home in 1 to 3 days with the least possible side effects. All these go a long way to get the patient the best possible treatment with minimal side effects. Cancer has been a rising threat with alarming statistics, in 2020 we saw around 13.25 lakh new cases of cancer in India, with 8.5 lakh deaths due to cancer. We must be cautious and concerned, it is estimated that by 2025, there will be 12% rise in cancer cases. It is a matter of concern that in 1990 there were 54 cancer patients per lakh population in Telangana and the incidence has since risen to 75 per lakh in less than three decades time. TrueBeam enables to access advanced care without the need for patients to go abroad, she added.Ms Shobana Kamineni, Executive Vice Chairperson Apollo Hospitals Groups said, the launch of the TrueBeam LINAC with Velocity is another milestone in Apollo Hospitals’ battle against cancer, one of the dreaded non-communicable diseases that in just the last year has seen over 13 lakh new cases and over 8.5 lakh deaths. With TrueBeam LINAC, our patients can rest assured that they will receive the most advanced radiotherapy techniques with the added benefits of a high degree of accuracy and a shorter treatment time for a successful treatment. In line with our move to an increased degree of digital healthcare, the Velocity software will provide our oncologists with the tools for data-driven clinical decision making that will help to reduce the mortality and morbidity from cancer. Apollo’s mission from day one has been to bring the best of care to every individual and to make it affordable. Many of the technologies we offer in our hospitals are the latest in the world available at a fraction of the treatment cost abroad. Not just Indians, many people from across the globe come to Apollo to find cure. There is no family in the world off late with someone developing Cancer, many have experienced the pain, which is evident from the statistics of 1 in 8 women in India will have breast cancer, the recurrence of cancers has seen a steep 50% increase from 1990 to 2020. Whatever resources with hospitals like ours with most proficient doctors with unparallel knowledge and skills are the warriors of today, who will be able to fight and make sure as Chairman Dr Prathap C. Reddy always says, cancer is no more a death knell.TrueBeam has been used for treating patients in over 90 countries and every year around 1.5 million patients receiving treatment on a TrueBeam linear accelerator (LINAC). TrueBeam is Varian’s most advanced LINAC, with the system incorporating many technical innovations that intuitively and dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. TrueBeam uses intelligent automation that not just simplifies the workflow, but also guides the specialists step-by-step through each radiotherapy treatment.The Velocity software organizes patient data and makes it available in one place, allowing the oncologist to access and compile treatment and imaging data from diverse systems for a comprehensive view of a patient’s diagnostic imaging and treatment history. This leads to more informed treatment decisions by facilitating close collaboration between physicians, oncologists, medical physicists, and others on the team. It also helps in cases of retreatment for recurrence or metastases.Dr Vijay Anand Reddy, Director Oncology Apollo Cancer Center Apollo Hospitals, Hyderabad said, “The TrueBeam platform with Velocity provides us with the tools to manage and treat our patients optimally. Many times, a patient has multiple treatments over a long period or even after a gap especially if metastatic lesions occur months or even years later. It is here that the Velocity software allows the treating doctors to understand a patient’s full clinical history and reach a judicious decision about the way forward. It puts more power into the hands of the oncologist with a comprehensive view of a patient’s diagnostic imaging and treatment history, regardless of where they were treated or what technology was used. Velocity makes it possible to manage the entire cancer treatment journey from diagnosis to completion of treatment.”About Apollo Hospitals:It was in 1983, that Dr. Prathap C Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai.Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals and 4100 pharmacies, over 120 Primary Care clinics and 650 Diagnostic centres, 700 plus Teleclinics, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials. The most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010.For 37 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.

Dr. Prathap C Reddy dedicates AICVD tool for prediction and prevention of heart disease to the physicians of the nation.National, September 27, 2021: Apollo Hospitals today announced the national launch of an AI (artificial intelligence) tool to predict risk of cardiovascular disease. The Apollo AI-powered Cardiovascular Disease Risk tool will help healthcare providers to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference. The cardiac risk scoring tool is remarkable for the speed in processing data and its accuracy at predicting the probability of a patient developing coronary disease. Using the tool, physicians will be enabled to deliver proactive, pre-emptive and preventive care for at-risk individuals, improving lives while mitigating future pressure on healthcare systems. On the occasion, Apollo Hospitals also announced that it has found pride of place in the Best Specialized Hospitals 2022 ranking released by Newsweek, the premier international news magazine and website. The ranking in partnership with global research firm Statista ranks the world’s best specialized hospitals and features the top 250 hospitals for cardiology and oncology and the top 150 for paediatrics among ten specialities. The Apollo Heart Centre at Apollo Hospitals, Chennai makes it to the list of Best Specialized Hospitals 2022 – Cardiology with a global rank of 126 and ranks No. 1 among the five Indian hospitals in the list.Also, in the Best Specialized Hospitals 2022 – Oncology, two hospitals from the Apollo Hospitals Group make it to the list with Apollo Cancer Centres at Apollo Speciality Cancer Hospital, Chennai and Apollo Hospitals, Chennai ranked at 228 and 239 respectively. The two hospitals are among just four Indian hospitals that are in list for Oncology. In the Paediatric speciality, Apollo Children’s Hospital, Chennai ranked at 103 globally and one among just five Indian hospitals that are part of the Best Specialized Hospitals 2022 – Paediatrics ranking.Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “The nation’s economy is intricately linked to the health of the people with non-communicable diseases (NCDs) leading to loss of productivity with a consequent impact on national income. While estimates suggest that NCDs account for an economic burden in the range of 5% to 10% of GDP, it is the chronic nature of NCDs, and their projected increase in prevalence, that will result in a growing economic impact if not addressed in time. Among the rising burden of NCDs, cardiovascular diseases (CVDs) figure at the top. Cardiovascular disease is the leading cause of death in the Asia Pacific, and it’s a problem that will only intensify as our populations continue to age. It’s also a problem that healthcare providers struggle to diagnose early enough to make a real difference.“While some predictive tools do exist to help physicians understand the probability of their patients developing heart disease, most of these are based on Western data sets and don’t take regional risk variations into account. This impacts their accuracy when applied in an Indian context. The Apollo AI-powered Cardiovascular Disease Risk tool will change that and put the knowledge and the means to predict and prevent heart disease in the physician’s hands. Available till now only to Apollo’s physicians, it is a proud moment for us to dedicate this AI tool to all physicians in the country.”Speaking on the Newsweek recognition, Dr. Prathap C Reddy added, “This global recognition is testament to the specialty healthcare of international standards provided at Apollo Hospitals with outcomes matching those of the world’s best hospitals. Apollo Hospitals, with some of the world’s finest and brightest medical experts, has been the pioneer in bringing ground-breaking healthcare technologies to India to deliver best in class clinical results.”The team at Apollo Hospitals collected more than ten years of data relating to 400,000 individuals across the country. Then, they used Microsoft Azure to turn that anonymized data into actionable insights that data scientists and clinicians could use to train machine learning models. The tool has been validated using data from the Maastricht Study, a long-term cohort health study in the Maastricht region and from the Heart+Vascular Center at Maastricht University Medical Center, Netherlands.Ms. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, “The AI tool to predict and prevent heart disease is the fruition of many years of research and development and stands testament to Apollo Hospitals’ technological prowess. Apollo’s AI-powered Cardiovascular Disease Risk Score is specifically for use in the Indian population, so physicians can better predict the risk of cardiac disease in their patients. The tool is built on algorithms based on ten years of anonymized data relating to around 400,000 individuals across the country collected by the team at Apollo Hospitals.“The tool has also been validated internationally using federated learning through Microsoft Azure Platform. Doctors across the Apollo network have been leveraging this AI-powered tool for three years to predict risk of cardiovascular disease and drive preventive cardiac care across the country. With this launch of the AI tool to predict risk of heart disease, we will be able to help achieve the World Health Organization’s goal of reducing the risk of premature mortality from non-communicable diseases, including CVDs, by 25% by 2025.”The AI-powered tool delivers a more accurate CVD risk score using algorithms specifically for the Indian population and helps in developing standardised care regimens. Developed using a combination of applied AI and clinical expertise on a large sample of retrospective data on health checks and coronary events, the tool delivers a risk score that takes into account all contributing factors including lifestyle attributes such as diet, tobacco & smoking preferences and physical activity as well as psychological stress and anxiety as reflected via rate of respiration, and hypertension. The risk is categorized into High, Moderate and Minimal. The tool also gives insights on the risk contributors that can be modified to improve the score. This enables physicians to give a more holistic advice to their patients with specific insights for lifestyle modification.

The Legend of the Year Cardiology & Cardiothoracic Surgery Dr. A.G.K. Gokhale Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. P.C. Rath Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. Sunil Kapoor Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. Vijay Dixit Apollo HospitalsThe Legend of the Year ENT Dr. E.C. Vinaya Kumar Apollo HospitalsThe Rising Star General Medicine Dr. Rajiv Paul Apollo HospitalsThe Legend of the Year Neurology & Neurosurgery Dr. Alok Ranjan Apollo HospitalsThe Legend of the Year Obstetrics & Gynecology Dr. Rooma Sinha Apollo HospitalsThe Rising Star Oncology Dr. T.P.S Bhandari Apollo HospitalsThe Legend of the Year Oncology Dr. Vijay Anand Reddy Apollo HospitalsThe Legend of the Year Ophthalmology Dr. Rajesh Fogla Apollo HospitalsThe Legend of the Year Orthopedics Dr. Jairamchander Pingle Apollo HospitalsThe Legend of the Year Urology Dr. K. Subrahmanyam Apollo Hospitals